319 News & Informationen zur Abbvie Aktie

  • Video
    Investflow

  • Video
    Investflow

  • Video
    echtgeld.tv

  • Global Respiratory Syncytial Virus Market 2021: Strong Product Pipeline is Expected to Support Growth - Forecast to 2027
    prnewswire.com

    Global Respiratory Syncytial Virus Market 2021: Strong Product Pipeline is Expected to Support Growth – Forecast to 2027

    /PRNewswire/ — The “Global Respiratory Syncytial Virus Market Size and Epidemiology (8MM), By Drug Type (Synagis, Other), By Dosage Form (Oral, Other), By…

  • Global Respiratory Syncytial Virus Market 2021: Strong Product Pipeline Is Expected To Support Growth - Forecast To 2027
    thestreet.com

    Global Respiratory Syncytial Virus Market 2021: Strong Product Pipeline Is Expected To Support Growth – Forecast To 2027

    DUBLIN, Aug. 31, 2021 /PRNewswire/ — The “Global Respiratory Syncytial Virus Market Size and Epidemiology (8MM), By Drug Type (Synagis, Other), By Dosage Form

  • Attention Biotech Investors: Mark Your Calendar For September PDUFA Dates
    markets.businessinsider.com

    Attention Biotech Investors: Mark Your Calendar For September PDUFA Dates

    August proved to be a mixed month for regulatory approvals, with the Food and Drug Administration approving a few, turning down a few others and d…

  • AbbVie: Is This Dividend Stock Overbought Or Will It Go Higher? (NYSE:ABBV)
    seekingalpha.com

    AbbVie: Is This Dividend Stock Overbought Or Will It Go Higher? (NYSE:ABBV)

    AbbVie is a beloved 'Dividend Aristocrat' currently yielding 4.4%. But the stock also is trading around a 52-week high. See if ABBV stock will go up.

  • 10 Dividend Aristocrats with Payout Ratio Less than 55%
    insidermonkey.com

    10 Dividend Aristocrats with Payout Ratio Less than 55%

    In this article, we will be taking a look at 10 dividend aristocrats with payout ratio less than 55%.

  • The Best Pharmaceutical Stocks to Add to Your Portfolio in 2021
    investmentu.com

    The Best Pharmaceutical Stocks to Add to Your Portfolio in 2021

    Over the course of the past year and a half, investors have been more focused on adding pharmaceutical stocks to bolster their portfolios.

  • Molecular Partners : Reports Corporate Highlights and Key Financials for H1 2021 (Form 6-K)
    marketscreener.com

    Molecular Partners : Reports Corporate Highlights and Key Financials for H1 2021 (Form 6-K)

    Molecular Partners Reports Corporate Highlights and Key Financials for H1 2021

    — Significant progress in COVID-19 trials, including positive results from healthy subjects and… | August 27, 2021

  • Pfizer's Covid Technology May Have Cancer Applications
    gurufocus.com

    Pfizer's Covid Technology May Have Cancer Applications

    GuruFocus Article or News written by Barry Cohen and the topic is about: The mRNA-produced vaccines are now being tested in lung and breast cancers

  • 10 Cheap Dividend Aristocrats to Buy Now
    insidermonkey.com

    10 Cheap Dividend Aristocrats to Buy Now

    In this article, we will be taking a look at 10 cheap dividend aristocrats to buy now.

  • Best Medical Marijuana Stocks To Buy In 2021? 2 Possible Long Term Investments Right Now
    marijuanastocks.com

    Best Medical Marijuana Stocks To Buy In 2021? 2 Possible Long Term Investments Right Now

    Could These Be Good Long Term Investments For Your Portfolio?

  • Molecular Partners Reports Corporate Highlights and Key Financials for H1 2021
    globenewswire.com

    Molecular Partners Reports Corporate Highlights and Key Financials for H1 2021

    — Significant progress in COVID-19 trials, including positive results from healthy subjects and COVID-19 patients, supporting the launch of ongoing…

  • 10 Best No-Fee DRIP Stocks to Buy Now
    insidermonkey.com

    10 Best No-Fee DRIP Stocks to Buy Now

    In this article, we will be taking a look at the 10 best no-fee DRIP stocks to buy now.

  • Who Are Pfizer's (PFE) Main Competitors?
    investopedia.com

    Who Are Pfizer's (PFE) Main Competitors?

    Pfizer's biggest competitors in the global pharmaceutical industry are Roche Holding, Eli Lilly, AbbVie, Novartis, and Merck.

  • Looking for Healthier Healthcare Stocks?
    etftrends.com

    Looking for Healthier Healthcare Stocks?

    The healthcare sector is getting its groove back, as a variety of exchange traded funds dedicated to the group are printing or residing near new highs.

  • Fiera Capital Corp Buys Jacobs Engineering Group Inc, The Descartes Systems Group Inc, Arista Networks Inc, Sells Churchill Downs Inc,...
    gurufocus.com

    Fiera Capital Corp Buys Jacobs Engineering Group Inc, The Descartes Systems Group Inc, Arista Networks Inc, Sells Churchill Downs Inc, Paycom Software Inc, Performance Food Group Co

    GuruFocus Article or News written by insider and the topic is about:

  • 5 Best Dividend Stocks to Buy Now
    moneymorning.com

    5 Best Dividend Stocks to Buy Now

    There’s enough for investors to worry about. But there are ways to have peace of mind when it comes to your portfolio. And these dividend stocks are just the thing…

  • Looking for a Healthier Healthcare ETF?
    etfdb.com

    Looking for a Healthier Healthcare ETF?

    The healthcare sector is getting its groove back, as a variety of exchange traded funds dedicated to the group are printing or residing near new highs.

  • Global Immunology Market to Surpass US$ 156,378.2 Million by 2028, Says Coherent Market Insights (CMI)
    globenewswire.com

    Global Immunology Market to Surpass US$ 156,378.2 Million by 2028, Says Coherent Market Insights (CMI)

    SEATTLE, Aug. 24, 2021 (GLOBE NEWSWIRE) — According to Coherent Market Insights, the global Immunology market is estimated to be valued at US$ 91,850…

  • Davidson Kempner Capital Management LP Buys , Willis Towers Watson PLC, , Sells , Qiagen NV, RealPage Inc
    gurufocus.com

    Davidson Kempner Capital Management LP Buys , Willis Towers Watson PLC, , Sells , Qiagen NV, RealPage Inc

    GuruFocus Article or News written by insider and the topic is about:

  • Glenview Trust Co Buys Comcast Corp, AbbVie Inc, Jupiter Wellness Inc, Sells PulteGroup Inc, Fiserv Inc,
    gurufocus.com

    Glenview Trust Co Buys Comcast Corp, AbbVie Inc, Jupiter Wellness Inc, Sells PulteGroup Inc, Fiserv Inc,

    GuruFocus Article or News written by insider and the topic is about:

  • Woodley Farra Manion Portfolio Management Inc Buys Progressive Corp, Raytheon Technologies Corp, International Business Machines Corp,...
    gurufocus.com

    Woodley Farra Manion Portfolio Management Inc Buys Progressive Corp, Raytheon Technologies Corp, International Business Machines Corp, Sells Novartis AG, Eaton Corp PLC, General Electric Co

    GuruFocus Article or News written by insider and the topic is about:

  • Warren Buffett Is Selling These 10 Stocks
    insidermonkey.com

    Warren Buffett Is Selling These 10 Stocks

    Warren Buffett, the chief of Nebraska-based Berkshire Hathaway, is often referred to as the “Sage of Omaha” due to his incredibly successful value investing strategy that has returned, on average, …

  • Level Four Financial, Llc Buys Compass EMP US EQIncome 100 Enhanced Volatity Wtd, VictoryShares US 500 Enhanced Volatility Wtd ETF,...
    gurufocus.com

    Level Four Financial, Llc Buys Compass EMP US EQIncome 100 Enhanced Volatity Wtd, VictoryShares US 500 Enhanced Volatility Wtd ETF, Alphabet Inc, Sells Amplify Transformational Data Sharing ETF, The S

    GuruFocus Article or News written by insider and the topic is about:

  • Fishman Jay A Ltd Buys Paysafe, AbbVie Inc, Bristol-Myers Squibb Company, Sells Macquarie Infrastructure Corp, Bausch Health Inc, Cisco...
    gurufocus.com

    Fishman Jay A Ltd Buys Paysafe, AbbVie Inc, Bristol-Myers Squibb Company, Sells Macquarie Infrastructure Corp, Bausch Health Inc, Cisco Systems Inc

    GuruFocus Article or News written by insider and the topic is about:

  • Stocks That Hit 52-Week Highs On Monday
    benzinga.com

    Stocks That Hit 52-Week Highs On Monday

    Before 10 a.m. ET on Monday, 119 companies hit new 52-week highs.
    Noteables: The largest company by market cap to set a new 52-week high was …

  • 500+ Aktien mit hoher Dividende September 2021 Liste! 5%+ Dividendenrendite!
    dividendenfluss.de

    500+ Aktien mit hoher Dividende September 2021 Liste! 5%+ Dividendenrendite!

    Du suchst Aktien mit hoher Dividende? In folgendem Artikel findest du 62 Aktien mit über 5% Dividendenrendite! Auch als Excel Download mit Kennzahlen!

  • 114 Aktien mit +25 Jahre Dividendenerhöhung aus den USA und Europa
    dividendenfluss.de

    114 Aktien mit +25 Jahre Dividendenerhöhung aus den USA und Europa

    Dividenden Aristokraten sind Aktien, welche mind. 25 Jahre lang Dividende zahlen und diese jedes Jahr erhöhen konnten. 114 Aktien aus US + EU erfüllen die Kriterien

  • SWS Partners Buys PureCycle Technologies Inc, Etsy Inc, Cloudflare Inc, Sells Marvell Technology Inc, Wayfair Inc, Salesforce.com Inc
    gurufocus.com

    SWS Partners Buys PureCycle Technologies Inc, Etsy Inc, Cloudflare Inc, Sells Marvell Technology Inc, Wayfair Inc, Salesforce.com Inc

    GuruFocus Article or News written by insider and the topic is about:

  • 10 Stocks that Helped Warren Buffett Make $4.6 Billion in Dividends
    insidermonkey.com

    10 Stocks that Helped Warren Buffett Make $4.6 Billion in Dividends

    In this article, we will be taking a look at 10 dividend stocks that helped Warren Buffett make $4.6 billion in dividends.

  • Global Anti-Inflammatory Therapeutics Market to Reach $130.9 Billion by 2026
    markets.businessinsider.com

    Global Anti-Inflammatory Therapeutics Market to Reach $130.9 Billion by 2026

    SAN FRANCISCO, Aug. 20, 2021 /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research comp…

  • Global Anti-Inflammatory Therapeutics Market to Reach $130.9 Billion by 2026
    prnewswire.com

    Global Anti-Inflammatory Therapeutics Market to Reach $130.9 Billion by 2026

    /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…

  • Global Atopic Dermatitis Drugs Market Report 2021: Rising Incident of Food Allergies Intensifying Atopic Dermatitis - Forecast to 2026
    markets.businessinsider.com

    Global Atopic Dermatitis Drugs Market Report 2021: Rising Incident of Food Allergies Intensifying Atopic Dermatitis – Forecast to 2026

    DUBLIN, Aug. 19, 2021 /PRNewswire/ — The 'Global Atopic Dermatitis Drugs Market (2021-2026) by Drug Class, Route of Administration, Geography, Co…

  • Waycross Partners, Llc Buys AbbVie Inc, Citigroup Inc, Intuit Inc, Sells PulteGroup Inc, Pioneer Natural Resources Co, General Electric Co
    gurufocus.com

    Waycross Partners, Llc Buys AbbVie Inc, Citigroup Inc, Intuit Inc, Sells PulteGroup Inc, Pioneer Natural Resources Co, General Electric Co

    GuruFocus Article or News written by insider and the topic is about:

  • Dermal Facial Fillers Market | Evolving Opportunities with AbbVie Inc. and Anika Therapeutics Inc. | Technavio
    prnewswire.com

    Dermal Facial Fillers Market | Evolving Opportunities with AbbVie Inc. and Anika Therapeutics Inc. | Technavio

    /PRNewswire/ — The dermal facial fillers market size is expected to reach a value of USD 1.45 billion at a CAGR of 9.14%, during 2021-2025. This marks a…

  • AbbVie wins court decision upholding Imbruvica patents (NYSE:ABBV)
    seekingalpha.com

    AbbVie wins court decision upholding Imbruvica patents (NYSE:ABBV)

    AbbVie <> has won a court ruling that upheld four patents linked to the cancer drug Imbruvica

  • AbbVie Stock: Bull Thesis Strengthened By Marginal ROCE Results (NYSE:ABBV)
    seekingalpha.com

    AbbVie Stock: Bull Thesis Strengthened By Marginal ROCE Results (NYSE:ABBV)

    I analyze AbbVie by examining its marginal efficiency of capital to gauge the future direction of its profitability. See how this strengthens my bullish thesis.

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Portrait der Abbvie Aktie

Das Unternehmen Abbvie aus USA ist in den Bereichen Chemie & Pharma, Biotechnologie & Pharmazeutika, Biotechnologie, Pharma tätig.

Abbvie ist in mehr als 87 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter First Trust Morningstar Dividend Leaders ETF (CAD-Hedged) gewichtet Abbvie mit 7,03% im ETF.

Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Abbvie Anleihen auf einen Blick.

Entdecke die 6 ETFs in denen Abbvie am höchsten gewichtet ist Insgesamt in 87 ETFs enthalten

Dir gefallen die Informationen zu Abbvie?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu Abbvie?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu Abbvie?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect

Dir gefallen die Informationen zu Abbvie?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba